Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin share news and announcements
2,113 announcements, routine notices left out, newest first. Page 37 of 43.
Jul 2011
12 Jul · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended June 30, 2011.4 Jul · Meeting
Annual General Meeting of the Company will be held on July 27, 2011. Further the Board of Directors have decided to close the Register of Members and Share Transfer Register from July 20, 2011 to July 27, 2011 (both days inclusive) for the purpose of Annual General Meeting and Dividend.
Jun 2011
May 2011
26 May · Business
Allotment Committee of Directors at its meeting held on May 26, 2011 has allotted 27550 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,25,95,198 consisting 44,62,97,599 equity shares of Rs. 2/- each.12 May · Dividend
Board of Directors of the Company at its meeting held on May 12, 2011 has recommended dividend @150% i.e. Rs.3/- per equity share of the face value of Rs.2/- each for the year ended March 31, 2011.12 May · Results
Consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 570682 lacs for year ending on 31-MAR-2011 against Rs. 474052 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 86255 lacs for the year ending on 31-MAR-2011 against Rs. 68163 lacs for the year ending on 31-MAR-2010.12 May · Results
Standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 442625 lacs for year ending on 31-MAR-2011 against Rs. 364009 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 80998 lacs for the year ending on 31-MAR-2011 against Rs. 64893 lacs for the year ending on 31-MAR-2010.
Apr 2011
28 Apr · Business
Allotment Committee of Directors at its meeting held on April 28, 2011 has allotted 68860 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,25,40,098 consisting 44,62,70,049 equity shares of Rs. 2/- each.21 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2011 and recommend dividend, if any.15 Apr · Disclosure
Company has granted 11,000 options to the employee of its subsidiary company, under "Lupin Subsidiary Companies Employees Stock Option Plan 2005", at the exercise price of Rs. 413.95 on April 14, 2011. One equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.7 Apr · Results
Last accounting year of the Company ended on March 31, 2011 and in terms of the time stipulated by Clause 41 of the Listing Agreement, the Company intend to finalise and publish the audited results for the said year before May 31, 2011. In view of the above, publication of the unaudited results for the last quarter i.e. January 01, 2011 to March 31, 2011 would not be necessary.
Mar 2011
22 Mar · Business
Allotment Committee of Directors at its meeting held on March 17, 2011 has allotted 52873 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,24,02,378 consisting 44,62,01,189 equity shares of Rs. 2/- each.21 Mar · Disclosure
Company has granted 50,000 options to its employee under "Lupin Employees Stock Option Plan 2003", at the exercise price of Rs. 391.60 on March 17, 2011. One equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.16 Mar · Updates
Board of Directors has approved the: (1)'Lupin Employees Stock Option Plan 2011', 'Lupin Subsidiary Companies Employees Stock Option Plan 2011', 'Lupin Employees Stock Purchase Program' and ' Lupin Stock Appreciation Rights Programme' to eligible employees of the company and its subsidiaries as per detailed schemes to be finalised by the Remuneration Committee of the Company, subject to such approvals as may be required. (2) Incorporation of a wholly-owned subsidiary of the Company by the name Lupin Healthcare Limited.
Feb 2011
8 Feb · Business
Allotment Committee of Directors at its meeting held on February 08, 2011 has allotted 43111 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,22,96,632 consisting 44,61,48,316 equity shares of Rs. 2/- each.
Jan 2011
27 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 116836 lacs for quarter ending on 31-DEC-2010 against Rs. 100450 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 24642 lacs for the quarter ending on 31-DEC-2010 against Rs. 22270 lacs for the quarter ending on 31-DEC-2009.27 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 146719 lacs for quarter ending on 31-DEC-2010 against Rs. 125543 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 22403 lacs for the quarter ending on 31-DEC-2010 against Rs. 16060 lacs for the quarter ending on 31-DEC-2009.13 Jan · Board meeting
Inter alia, to consider the unaudited financial results for the quarter ended December 31, 2010.7 Jan · Business
Allotment Committee of Directors at its meeting held on January 7, 2011 has allotted 203155 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,22,10,410 consisting 44,61,05,205 equity shares of Rs. 2/- each.
Dec 2010
14 Dec · Disclosure
Company has granted 50000 option under "Lupin Employees Stock Option Plan 2005" at the exercise price of Rs.226.65 on December 13, 2010. One equity share of Rs. 2/- each is covered by each option. The Options issued are exercisable after a minimum vesting period of 12 month but before the exercise period of 10 years from the date of grant.6 Dec · Business
Allotment Committee of Directors at its meeting held on December 06, 2010 has allotted 25875 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,18,04,100 consisting 44,59,02,050 equity shares of Rs. 2/- each.
Nov 2010
22 Nov · Business
Allotment Committee of Directors at its meeting held on November 22, 2010 has allotted 105105 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,17,52,350 consisting 44,58,76,175 equity shares of Rs. 2/- each.1 Nov · Management
Board of Directors of the Company at their meeting held on November 01, 2010, the Board has:-(1) Re-appointed Dr. Desh Bandhu Gupta as Executive Chairman and Mrs. M. D. Gupta as Executive Director of the Company, for a period of five years w.e.f. January 01, 2011. The same shall be subject to approval of the shareholders.